Nutritional genomics

United States Nutrigenomics Markets, Competition, Forecast, and Opportunities, 2028F: Bridging Nutrition and Genetics - Market Gears Up for Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 17, 2023

One of the uses of genomics is nutrigenomics, which focuses on the investigation of how nutrition affects gene expression and metabolic pathways.

Key Points: 
  • One of the uses of genomics is nutrigenomics, which focuses on the investigation of how nutrition affects gene expression and metabolic pathways.
  • Due to the rising incidence of lifestyle disorders, including diabetes and obesity, the worldwide nutrigenomics industry is anticipated to experience enormous growth.
  • Therefore, the high cost of implementation is anticipated to limit the growth of the US Nutrigenomics market.
  • Company Profiles: Detailed analysis of the major companies present in the United States Nutrigenomics Market.

Global Direct-to-Consumer Genetic Testing Market Report 2023: Sector is Expected to Reach $8.8 Billion by 2030 at a CAGR of 24.3% - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 11, 2023

The global direct-to-consumer genetic testing market size is expected to reach USD 8.8 billion by 2030, expandingat a CAGR of 24.3% from 2023 to 2030.

Key Points: 
  • The global direct-to-consumer genetic testing market size is expected to reach USD 8.8 billion by 2030, expandingat a CAGR of 24.3% from 2023 to 2030.
  • The major drivers of market growth include increasing awareness about the potential benefits of genetic testing, growing demand for personalized medicine, and decreasing the cost of genomic sequencing.
  • Moreover, the number of companies offering direct-to-consumer (DTC) genetic testing services has increased, offering consumers a wider range of options.
  • The marketplace is moderately fragmented, with a large number of medium and large-sized companies accounting for the majority revenue of the market.

PHBI Pharmgreen Launches Online Sales for Its MaxGenomic™ Supplement Product

Retrieved on: 
Wednesday, February 8, 2023

MaxGenomic™ Supplement comes in a bottle with 60 Enteric capsules (delayed release), for a one- or two-month supply, depending on suggested use.

Key Points: 
  • MaxGenomic™ Supplement comes in a bottle with 60 Enteric capsules (delayed release), for a one- or two-month supply, depending on suggested use.
  • This all-natural product utilizes a combination of fifteen ingredients from medicinal plants and medicinal mushrooms.
  • Online store is now open, please visit: https://pharmagreen-store.myshopify.com/
    Pharmagreen’s team focus is to help and aid, in the sales of MaxGenomic™ Supplement and additional nutraceutical products development.
  • “This is a very great start to the new year, as we have started the sales program of our very unique MaxGenomic™ Supplement brand.

Global Nutrigenomics Market Report 2022 to 2035: Industry Trends and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, December 2, 2022

The "Nutrigenomics Market by Type of Sample, Type of Sample Collection Method and Key Geographies: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Nutrigenomics Market by Type of Sample, Type of Sample Collection Method and Key Geographies: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.
  • This report features an extensive study of the current landscape and future potential of the nutrigenomics focused companies.
  • The study features an in-depth analysis, highlighting the capabilities of nutrigenomics focused companies.
  • How is the current and future market opportunity likely to be distributed across key segments?

Pharmagreen Appoints Tyrell Crosby, a Professional Athlete, as Its Honorary Sports Ambassador

Retrieved on: 
Tuesday, November 29, 2022

CARSON CITY, NV, Nov. 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), (Pharmagreen or the Company) is pleased to announce that Mr. Tyrell Crosby, a professional NFL player, has joined the Pharmagreen team to be an Honorary Sports Ambassador for Pharmagreens NutraMax Genomic Supplement product line.

Key Points: 
  • CARSON CITY, NV, Nov. 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), (Pharmagreen or the Company) is pleased to announce that Mr. Tyrell Crosby, a professional NFL player, has joined the Pharmagreen team to be an Honorary Sports Ambassador for Pharmagreens NutraMax Genomic Supplement product line.
  • Tyrell will attend gatherings, trade shows, and other scheduled events selected by Pharmagreen, and will provide his endorsement of NutraMax products on various online social media platforms.
  • Pharmagreens proprietary blend is unique to the market, a nutrigenomic supplement for the utmost mind and body experience.
  • Pharmagreen is focused on developing its product and becoming a household brand worldwide in support of everyones everyday wellbeing.

PHBI Pharmagreen Develops a Proprietary Nutraceutical Formulation and Prepares for Product Launch

Retrieved on: 
Thursday, September 8, 2022

The Pharmagreen team is very excited to be launching this nutraceutical product utilizing a combination of fifteen ingredients from medicinal plants and mushrooms.

Key Points: 
  • The Pharmagreen team is very excited to be launching this nutraceutical product utilizing a combination of fifteen ingredients from medicinal plants and mushrooms.
  • Pharmagreens proprietary blend is unique to the market, a nutrigenomic supplement for the utmost mind and body experience.
  • Pharmagreen created this new line of genomic supplements because health and wellness start on the cellular level.
  • Pharmagreen is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product.

Organ-On-Chip Market Size to Grow USD 81.2 Million by 2028 with a CAGR of 39.1% | Valuates Reports

Retrieved on: 
Monday, July 11, 2022

- The global Orphan Drugs market size is projected to reach USD 241610 Million by 2027, from USD 122720 Million in 2020, at a CAGR of 9.7% during 2021-2027.

Key Points: 
  • - The global Orphan Drugs market size is projected to reach USD 241610 Million by 2027, from USD 122720 Million in 2020, at a CAGR of 9.7% during 2021-2027.
  • - The global Genomics market size is projected to reach USD 31240 Million by 2027, from USD 15120 Million in 2020, at a CAGR of 10.8% during 2021-2027.
  • - The global Nutrigenomics market size is projected to reach USD 20990 Million by 2027, from USD 10770 Million in 2020, at a CAGR of 9.5% during 2021-2027.
  • - The global Laboratory Automation market size is projected to reach USD 5121.4 Million by 2028, from USD 3695.5 Million in 2021, at a CAGR of 4.3% during 2022-2028.

Organ-On-Chip Market Size to Grow USD 81.2 Million by 2028 with a CAGR of 39.1% | Valuates Reports

Retrieved on: 
Monday, July 11, 2022

- The global Orphan Drugs market size is projected to reach USD 241610 Million by 2027, from USD 122720 Million in 2020, at a CAGR of 9.7% during 2021-2027.

Key Points: 
  • - The global Orphan Drugs market size is projected to reach USD 241610 Million by 2027, from USD 122720 Million in 2020, at a CAGR of 9.7% during 2021-2027.
  • - The global Genomics market size is projected to reach USD 31240 Million by 2027, from USD 15120 Million in 2020, at a CAGR of 10.8% during 2021-2027.
  • - The global Nutrigenomics market size is projected to reach USD 20990 Million by 2027, from USD 10770 Million in 2020, at a CAGR of 9.5% during 2021-2027.
  • - The global Laboratory Automation market size is projected to reach USD 5121.4 Million by 2028, from USD 3695.5 Million in 2021, at a CAGR of 4.3% during 2022-2028.

$10 Billion Home DNA Test Kit Market Opportunity Forecasts, 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 20, 2022

The "Home DNA Test Kit Market Opportunity Forecast 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Home DNA Test Kit Market Opportunity Forecast 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global home genetic testing kit market is expected to surpass US$ 10 Billion by 2028.
  • The report covers a detailed study of home genetic testing kit market size, growth and share, trends, consumption, segments, application, and forecast till 2028.
  • Home DNA Test Kit Market Opportunity Forecast 2028 Report Highlights:
    Kits Availability & Price Analysis by Company, Country & Indication
    Global Home Genetic Testing Kit Market by Application: Ancestry, Nutrigenomics, Parenting, Chronic Diseases
    Global Home Genetic Testing Kit Market by Country: US, UK, china, India, Japan, South Korea, Taiwan, Singapore, Malaysia, Turkey, Russia, Canada, Middle East, Australia
    In last few decades, the field of genetics has witnessed rapid evolution which has eventually led to the development of genetic tests.

Global Nutrigenomics Markets, Analysis, Competition, Opportunity, and Forecasts, 2016-2021 & 2022-2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, March 28, 2022

The "Global Nutrigenomics Market, By Product & Services (Services {Nutrigenomics Genetic Testing}, Product), By Technique (Saliva/Buccal Swab, Blood, Others), By Application, By Region, Competition, Opportunity, and Forecast, 2016-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Nutrigenomics Market, By Product & Services (Services {Nutrigenomics Genetic Testing}, Product), By Technique (Saliva/Buccal Swab, Blood, Others), By Application, By Region, Competition, Opportunity, and Forecast, 2016-2026" report has been added to ResearchAndMarkets.com's offering.
  • The Global Nutrigenomics Market is anticipated to grow on the grounds of increasing demand for nutritious and healthy food alternatives.
  • Growing concerns among the population and thus the shift toward healthier food, and its influence on the genetic morphology of the global population, is driving the growth of the Global Nutrigenomics Market in the upcoming five years.
  • Diet concerns and demand for adequate nutrients in the diet for athletes and sports players are also responsible for the growth of the Global Nutrigenomics Market in the future five years.